Evidence map›Paper›PMID 42213356›Full record

ReviewFolia microbiologica2026

Gnotobiotic mouse models as tools for dissecting the role of the microbiota in allergy: contributions from the laboratory of gnotobiology in Nový Hrádek.

I Schabussova, H Kozakova, A Inic-Kanada, U Wiedermann, T Hrncir, T Hudcovic, D Srutkova, M Schwarzer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

I SchabussovaInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria. irma.schabussova@meduniwien.ac.at.ORCID http://orcid.org/0000-0002-2109-2640
H KozakovaLaboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Nový Hrádek, Czech Republic.ORCID http://orcid.org/0000-0001-7352-5922
A Inic-KanadaInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria.ORCID http://orcid.org/0000-0001-7854-3812
U WiedermannInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Kinderspitalgasse 15, Vienna, 1090, Austria.ORCID http://orcid.org/0000-0002-1302-3223
T HrncirLaboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Nový Hrádek, Czech Republic.
T HudcovicLaboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Nový Hrádek, Czech Republic.ORCID http://orcid.org/0000-0002-5320-4504
D SrutkovaLaboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Nový Hrádek, Czech Republic.ORCID http://orcid.org/0000-0003-0054-5396
M SchwarzerLaboratory of Gnotobiology, Institute of Microbiology of the Czech Academy of Sciences, Nový Hrádek, Czech Republic.ORCID http://orcid.org/0000-0002-1401-6578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gnotobiotic mouse models occupy a unique position in allergy research as the only systems that allow causal links between defined microbial inputs and specific immune outcomes. This review summarises the long-term contributions of the Laboratory of Gnotobiology at the Institute of Microbiology of the Czech Academy of Sciences in Nový Hrádek, covering two decades of mechanistic research following the germ-free (GF) models pioneered by Professor Jaroslav Šterzl. The review is structured around three themes. First, GF BALB/c mice retain full capacity for Th2 sensitisation and mucosal tolerance, but allergy outcomes are strongly influenced by endotoxin content of the mouse chow, an often overlooked variable that should be explicitly controlled. Second, defined microbial colonisation during the perinatal period reduces allergic sensitisation through mechanisms including mucosal tolerance induction, tolerogenic dendritic cell programming, gut barrier restoration, and regulatory immune responses. Third, the microbiota is required not only for sensitisation but also for development of the intestinal mast cell effector compartment that mediates IgE-dependent disease; this function is not restored by a single probiotic strain and likely requires greater microbial complexity. Together, these findings define microbiota-allergy interactions in mechanistic terms. They identify dietary endotoxin as a key experimental confound and establish the perinatal period (encompassing maternal and neonatal microbial exposure) as critical for both prevention of sensitisation and maturation of effector responses. They also show that single-strain probiotics and complex microbiota reconstitution target distinct components of allergic disease. The review concludes by highlighting methodological considerations, open questions, and future directions, including postbiotics and extracellular vesicle-based approaches in allergy modulation.

Indexed as

AllergyGerm-free miceGnotobiologyMicrobiotaNový HrádekProbiotic bacteria

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.